WHAT CAN WE HELP YOU FIND?

Skip to content

NEWS

June 1, 2022

Monkeypox Resources

Public Health Ontario has developed interim guidance on the use of the smallpox vaccine Imvamune as post-exposure prophylaxis (PEP) against Monkeypox (attached).  Of note, clinical trials of Imvamune have included people living with HIV with a CD4 count of greater than 100.  For people with more severe immunosuppression, an additional risk/benefit discussion is indicated before using the vaccine as post-exposure prophylaxis.  The guidelines outline when it may be appropriate to use Imvamune as a Monkeypox PEP. You can review this doc here.

The Gay Men’s Sexual Health Alliance (GMSH) is maintaining a webpage where current information is available, in plain language, on ‘what we know’:  https://gmsh.ca/monkeypox/

The Toronto Public Health webpage on Monkeypox includes information on symptoms, treatment and prevention, as well as current case counts in Toronto:  https://www.toronto.ca/community-people/health-wellness-care/health-programs-advice/monkeypox/

Public Health Ontario has a webpage where information and guidance is available to support the public health response (https://www.publichealthontario.ca/en/Diseases-and-Conditions/Infectious-Diseases/Vector-Borne-Zoonotic-Diseases/Monkeypox).

 

 

 

Monkeypox Interim Vaccine Guidance QA_v10 Final
X